Neurocrine Biosciences Announces Conference Call and Webcast of Fourth Quarter and Year-End 2023 Financial Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Get Ready For The New Biotech Bull Market (NYSEARCA:XBI) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences to Host Analyst Day on December 5, 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) – Analysts at Cantor Fitzgerald increased their FY2024 earnings per share (EPS) estimates for Neurocrine Biosciences in a report released on Wednesday, November 1st. Cantor Fitzgerald analyst J. Schimmer now forecasts that the company will earn $4.85 per share for the year, up from their prior forecast of […]
SAN DIEGO - Neurocrine Biosciences, Inc. today announced interim results from the ongoing open-label KINECT-HD2 study about INGREZZA capsules when used for the long-term treatment of adults with.